Online Direct-to-Consumer Advertising of Stem Cell Therapy for Musculoskeletal Injury and Disease

2020 ◽  
Vol 102 (1) ◽  
pp. 2-9 ◽  
Author(s):  
Matthew T. Kingery ◽  
Lauren Schoof ◽  
Eric J. Strauss ◽  
Joseph A. Bosco ◽  
Joanne Halbrecht
2021 ◽  
Author(s):  
Mirna Hassoun ◽  
Sidney Golub ◽  
Sheldon Greenfield ◽  
Joshua D Grill ◽  
Brian J Cummings

Aim: To attend stem-cell (SC) seminars hosted by US-based direct-to-consumer SC businesses either in person or via online ‘webinars’ to determine accuracy and regulatory oversight of the advertised SC therapies. Methods: The therapeutic claims, costs, risks, scientific evidence in support of a therapy and any regulatory oversight were collated using pre-established checklists. Participation consisted of one live attendance of a seminar, and following COVID-19 restrictions, review of seven recorded presentations available on the internet from SC businesses. Results & conclusion: None of the SC therapies advertised by direct-to-consumer clinics reviewed were supported by proper clinical evidence nor substantiated by peer reviewed literature.


2020 ◽  
Vol 60 (4) ◽  
pp. 179-192
Author(s):  
Jodi C. Hwang ◽  
Patrick C. Staropoli ◽  
Ajay E. Kuriyan ◽  
Nicolas A. Yannuzzi ◽  
Jayanth Sridhar

2019 ◽  
Vol 25 (4) ◽  
pp. 7
Author(s):  
Milica Maslovaric ◽  
Nikola Fatic ◽  
Emilija Delević

Sign in / Sign up

Export Citation Format

Share Document